Integrated Diagnostics Holdings plc

LSE:IDHC Stok Raporu

Piyasa değeri: US$289.2m

Integrated Diagnostics Holdings Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 6/6

Integrated Diagnostics Holdings has been growing earnings at an average annual rate of 2.9%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 13.9% per year. Integrated Diagnostics Holdings's return on equity is 20.8%, and it has net margins of 17.2%.

Anahtar bilgiler

2.9%

Kazanç büyüme oranı

2.9%

EPS büyüme oranı

Healthcare Sektör Büyümesi12.6%
Gelir büyüme oranı13.9%
Özkaynak getirisi20.8%
Net Marj17.2%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around

Nov 07
Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around

Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?

Oct 17
Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?

Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)

Jun 22
Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)

Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit

Nov 25
Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit

Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?

Sep 06
Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?

Gelir ve Gider Dağılımı

Integrated Diagnostics Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

LSE:IDHC Gelir, gider ve kazançlar (EGP Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 244,7488178740
31 Mar 244,3787557780
31 Dec 234,1235107730
30 Sep 233,8585387580
30 Jun 233,5233427370
31 Mar 233,3404176860
31 Dec 223,6055416190
30 Sep 224,2587166130
30 Jun 224,8861,1885780
31 Mar 225,2761,3835870
31 Dec 215,2251,4135580
30 Sep 214,7531,3224930
30 Jun 214,0001,0624470
31 Mar 213,2868164010
31 Dec 202,6565943710
30 Sep 202,2475235770
30 Jun 202,1154663510
31 Mar 202,1804913880
31 Dec 192,2265113140
30 Sep 192,1935082610
30 Jun 192,1175102850
31 Mar 192,0355182050
31 Dec 181,9215022650
30 Sep 181,7904471860
30 Jun 181,6954352220
31 Mar 181,6054052070
31 Dec 171,5143741920
30 Sep 171,4253431590
30 Jun 171,3032921740
31 Mar 171,2372761660
31 Dec 161,1712601590
30 Sep 161,1162472640
30 Jun 161,0742512810
31 Mar 161,0441982720
31 Dec 151,0151452640
30 Sep 159801341210
30 Jun 15937931270
31 Mar 158981131240
31 Dec 148601331210
30 Sep 14807105920
31 Dec 1367262920

Kaliteli Kazançlar: IDHC has high quality earnings.

Büyüyen Kar Marjı: IDHC's current net profit margins (17.2%) are higher than last year (9.7%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: IDHC's earnings have grown by 2.9% per year over the past 5 years.

Büyüme Hızlandırma: IDHC's earnings growth over the past year (138.6%) exceeds its 5-year average (2.9% per year).

Kazançlar vs. Sektör: IDHC earnings growth over the past year (138.6%) exceeded the Healthcare industry 12.1%.


Özkaynak Getirisi

Yüksek ROE: IDHC's Return on Equity (20.8%) is considered high.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin